Synthesis, Characterization and Biological Evaluation of Aurones As Potential Neuroprotective Agents

Overview

Journal Future Med Chem

Specialties Chemistry
Pharmacy

Date 2024 Jun 28

PMID 38940451

Authors

Muhammad Ayaz

Syed Wadood Ali Shah

Mohammad Shoaib

Fawad Ali Shah

Fawad Ahmed

Affiliations

Soon will be listed here.

Abstract

To synthesize aurone (Ar) derivatives and to demonstrate their effects against diabetes mellitus (DM) and neurodegeneration. Five Ar () derivatives were synthesized, characterized by proton NMR and screened for antioxidant, anti-diabetic and anti-cholinesterase activities. They were further evaluated for neuroprotective effects in streptozotocin (STZ)-induced neurodegenerative model. Among the aurone derivatives ArE demonstrated significant reversal of cognitive impairment, oxidative stress and neuroinflammation. Biochemical analysis revealed anti-diabetic and neuroprotective effects, possibly through downregulation of inflammatory markers and upregulation of antioxidant enzymes. Synthesized Ar () exhibits promising therapeutic potential against STZ-induced neurodegeneration and DM by modulating inflammatory and oxidative pathways, suggesting a novel avenue for disease management.

References

Gawel S, Wardas M, Niedworok E, Wardas P . [Malondialdehyde (MDA) as a lipid peroxidation marker]. Wiad Lek. 2005; 57(9-10):453-5. View

Arai K, Matsuki N, Ikegaya Y, Nishiyama N . Deterioration of spatial learning performances in lipopolysaccharide-treated mice. Jpn J Pharmacol. 2002; 87(3):195-201. DOI: 10.1254/jjp.87.195. View

Malarde L, Rebillard A, Le Douairon-Lahaye S, Vincent S, Zguira M, Lemoine-Morel S . Superoxide production pathways in aortas of diabetic rats: beneficial effects of insulin therapy and endurance training. Mol Cell Biochem. 2013; 389(1-2):113-8. DOI: 10.1007/s11010-013-1932-z. View

Cai Z . Monoamine oxidase inhibitors: promising therapeutic agents for Alzheimer's disease (Review). Mol Med Rep. 2014; 9(5):1533-41. DOI: 10.3892/mmr.2014.2040. View

Di Stefano A, Reale M . Editorial: Neurodegenerative Disorders: Synthesis, Drug Delivery Strategies and Biological Evaluation of New Therapeutic Agents. Cent Nerv Syst Agents Med Chem. 2017; 17(2):89. DOI: 10.2174/187152491702170712214058. View

Engstrom A, Snyder J, Maeda N, Xia Z . Gene-environment interaction between lead and Apolipoprotein E4 causes cognitive behavior deficits in mice. Mol Neurodegener. 2017; 12(1):14. PMC: 5297175. DOI: 10.1186/s13024-017-0155-2. View

Duraes F, Pinto M, Sousa E . Old Drugs as New Treatments for Neurodegenerative Diseases. Pharmaceuticals (Basel). 2018; 11(2). PMC: 6027455. DOI: 10.3390/ph11020044. View

Park H, Nelson D, Taylor Z, Hayes J, Cunningham K, Arivett B . Suppression of LPS-induced NF-κB activity in macrophages by the synthetic aurone, (Z)-2-((5-(hydroxymethyl) furan-2-yl) methylene) benzofuran-3(2H)-one. Int Immunopharmacol. 2016; 43:116-128. DOI: 10.1016/j.intimp.2016.12.004. View

Li S, Zhang Q, Ding Y, Wang X, Liu P . Flavonoids ameliorate aluminum chloride-induced learning and memory impairments via suppression of apoptosis and oxidative stress in rats. J Inorg Biochem. 2020; 212:111252. DOI: 10.1016/j.jinorgbio.2020.111252. View

10.

Karvekar O, Vadanagekar A, Sarvalkar P, Suryawanshi S, Jadhav S, Singhan R . Bos taurus (A-2) urine assisted bioactive cobalt oxide anchored ZnO: a novel nanoscale approach. Sci Rep. 2022; 12(1):15584. PMC: 9481578. DOI: 10.1038/s41598-022-19900-3. View

11.

Song M, Jeong G, Kwon K, Ka S, Jang H, Park J . Sulfuretin protects against cytokine-induced beta-cell damage and prevents streptozotocin-induced diabetes. Exp Mol Med. 2010; 42(9):628-38. PMC: 2947020. DOI: 10.3858/emm.2010.42.9.062. View

12.

Shoaib M, Ghias M, Ali Shah S, Ali N, Naveed Umar M, - A . Synthetic flavonols and flavones: A future perspective as anticancer agents. Pak J Pharm Sci. 2019; 32(3):1081-1089. View

13.

Heemels M . Neurodegenerative diseases. Nature. 2016; 539(7628):179. DOI: 10.1038/539179a. View

14.

Gitler A, Dhillon P, Shorter J . Neurodegenerative disease: models, mechanisms, and a new hope. Dis Model Mech. 2017; 10(5):499-502. PMC: 5451177. DOI: 10.1242/dmm.030205. View

15.

Onozuka H, Nakajima A, Matsuzaki K, Shin R, Ogino K, Saigusa D . Nobiletin, a citrus flavonoid, improves memory impairment and Abeta pathology in a transgenic mouse model of Alzheimer's disease. J Pharmacol Exp Ther. 2008; 326(3):739-44. DOI: 10.1124/jpet.108.140293. View

16.

Lockridge O . Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses. Pharmacol Ther. 2014; 148:34-46. DOI: 10.1016/j.pharmthera.2014.11.011. View

17.

Geula C, Mesulam M . Cholinesterases and the pathology of Alzheimer disease. Alzheimer Dis Assoc Disord. 1995; 9 Suppl 2:23-8. DOI: 10.1097/00002093-199501002-00005. View

18.

Ono M, Maya Y, Haratake M, Ito K, Mori H, Nakayama M . Aurones serve as probes of beta-amyloid plaques in Alzheimer's disease. Biochem Biophys Res Commun. 2007; 361(1):116-21. DOI: 10.1016/j.bbrc.2007.06.162. View

19.

Brettschneider J, Del Tredici K, Lee V, Trojanowski J . Spreading of pathology in neurodegenerative diseases: a focus on human studies. Nat Rev Neurosci. 2015; 16(2):109-20. PMC: 4312418. DOI: 10.1038/nrn3887. View

20.

Putteeraj M, Lim W, Teoh S, Yahaya M . Flavonoids and its Neuroprotective Effects on Brain Ischemia and Neurodegenerative Diseases. Curr Drug Targets. 2018; 19(14):1710-1720. DOI: 10.2174/1389450119666180326125252. View